AP - Federal regulators have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been ratcheting up fears that patients, particularly children with leukemia, would miss lifesaving treatments.
facebook ipo facebook ipo mike kelley right to work puxatony phil college football recruiting rankings josh harvey clemons
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.